Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000147414 | SCV000225115 | likely benign | not specified | 2014-11-15 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000147414 | SCV000304850 | benign | not specified | 2018-01-16 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000298868 | SCV000413028 | likely benign | Central core myopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000355981 | SCV000413029 | likely benign | Neuromuscular disease, congenital, with uniform type 1 fiber | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000263490 | SCV000413030 | likely benign | Malignant hyperthermia, susceptibility to, 1 | 2018-02-22 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000330379 | SCV000413031 | likely benign | Congenital multicore myopathy with external ophthalmoplegia | 2018-02-22 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Gene |
RCV000147414 | SCV000528803 | benign | not specified | 2016-08-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Athena Diagnostics | RCV000147414 | SCV000614902 | benign | not specified | 2016-09-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001081860 | SCV000659855 | benign | RYR1-related disorder | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000551499 | SCV001151909 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | RYR1: BP4, BS2 |
Fulgent Genetics, |
RCV002498670 | SCV002806440 | benign | Central core myopathy; Malignant hyperthermia, susceptibility to, 1; Congenital multicore myopathy with external ophthalmoplegia; Congenital myopathy with fiber type disproportion; King Denborough syndrome | 2021-07-23 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000263490 | SCV004358230 | benign | Malignant hyperthermia, susceptibility to, 1 | 2022-04-29 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000263490 | SCV004816270 | benign | Malignant hyperthermia, susceptibility to, 1 | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000147414 | SCV000194809 | likely benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000551499 | SCV001800011 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000147414 | SCV001958381 | benign | not specified | no assertion criteria provided | clinical testing |